XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenue:    
Product sales, net $ 677  
Type of Revenue [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Cost of sales:    
Cost of product sales $ 236  
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Gross profit $ 441  
Operating expenses:    
Research and development 2,681 $ 2,552
Selling, general and administrative 4,581 2,165
Total operating expenses 7,262 4,717
Operating loss (6,821) (4,717)
Other income (expense):    
Other income 11 59
Change in fair value of derivative financial instruments 8,289 2,525
Foreign exchange gain (loss) (155) 968
Total other income 8,145 3,552
Net income (loss) 1,324 (1,165)
Other comprehensive income (loss):    
Foreign currency translation adjustments (112) (953)
Comprehensive income (loss) $ 1,212 $ (2,118)
Net income (loss) per share    
Basic $ 0.05 $ (0.06)
Diluted $ (0.06) $ (0.08)
Weighted average shares outstanding    
Basic 25,832,190 20,334,929
Diluted 26,785,708 20,460,656